Vaccination News

Data from more than 3 million participants in the National COVID Cohort Collaborative revealed that SARS-CoV-2 reinfections have similar severity to initial infections.

The severity of a SARS-CoV-2 reinfection is likely to be similar to the severity of a patient’s initial infection, researchers found.

A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.

The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.

The FDA’s recent authorization of a rapid, point-of-care test to diagnose current hepatitis C virus infection is a major victory, but it would be malpractice to initiate same-day HCV treatment if a patient’s hepatitis B virus status is unknown.

HHS will give Moderna approximately $176 million to support the development of a messenger RNA pandemic influenza vaccine, according to an agency press release.

As health care workers, we have daily encounters with sick patients who could potentially have a contagious illness. Measles is a particular challenge in the health care setting.

Rather than telling a patient they should get a vaccine, the CDC’s shared clinical decision-making recommendations advise patients to speak to providers about certain vaccines and decide on an individual basis if they should receive them. 

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

CHICAGO — HPV vaccination rates for children and young adults increased substantially during the 2010s regardless of gender, race or ethnicity, according to findings presented at ASCO Annual Meeting.